Question: In Section 21.7, we described how Valeant and its ally, Pershing Square, lost the battle to acquire Allergan. Sometimes, the losers in a takeover battle

In Section 21.7, we described how Valeant and its ally, Pershing Square, lost the battle to acquire Allergan. Sometimes, the losers in a takeover battle can also win if they own a toehold stake in the target's stock. Between April and June 2014, Pershing acquired a 9.7% stake in Allergan at an estimated average price of $128 a share. In November, Actavis offered $219 per share for each of Allergan's 299 million shares. What was Pershing's profit on its holding?

Step by Step Solution

3.45 Rating (161 Votes )

There are 3 Steps involved in it

1 Expert Approved Answer
Step: 1 Unlock

A 97 stake in 299 million shares is 29 ... View full answer

blur-text-image
Question Has Been Solved by an Expert!

Get step-by-step solutions from verified subject matter experts

Step: 2 Unlock
Step: 3 Unlock

Document Format (1 attachment)

Word file Icon

1280-B-C-F-S(1544).docx

120 KBs Word File

Students Have Also Explored These Related Corporate Finance Questions!